Education
About Us
Working with TipRanks
Follow Us
Faron Pharmaceuticals Oy (GB:FARN)
LSE:FARN
Total Valuation
Faron Pharmaceuticals Oy has a market cap or net worth of £232.44M. The enterprise value is 66.58M.
Market Cap£232.44M
Enterprise Value66.58M
Share Statistics
Faron Pharmaceuticals Oy has 111,601,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding111,601,610
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Faron Pharmaceuticals Oy’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count25
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Faron Pharmaceuticals Oy is ―. Faron Pharmaceuticals Oy’s PEG ratio is ―.
PE Ratio―
PS Ratio725.43
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Faron Pharmaceuticals Oy had revenue of ― and earned -28.73M in profits. Earnings per share was ―.
Revenue―
Gross Profit803.00K
Operating Income-27.43M
Pretax Income―
Net Income-28.73M
EBITDA-27.05M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Faron Pharmaceuticals Oy pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.89
52-Week Price Change99.11%
50-Day Moving Average189.18
200-Day Moving Average184.06
Relative Strength Index (RSI)51.17
Average Volume (3m)103.29K
Important Dates
Faron Pharmaceuticals Oy upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Faron Pharmaceuticals Oy as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Faron Pharmaceuticals Oy has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Faron Pharmaceuticals Oy EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Faron Pharmaceuticals Oy has ― in cash and marketable securities with 2.36M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt2.36M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Faron Pharmaceuticals Oy is £534.18, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£534.18
Price Target Upside154.37% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―